Quantcast
Channel: cafepharma - Durect Corporation
Browsing all 20 articles
Browse latest View live

News

DURECT Corporation Secures $50 Million Committed Equity Financing Facility Trading Markets

View Article



News

Pain Therapeutics gets June 23 FDA date for Remoxy Yahoo/AP

View Article

Durect pain patch Eladur fails in midstage study on chronic lower back pain

Durect pain patch Eladur fails in midstage study on chronic lower back pain Yahoo/AP

View Article

4 Pharma Stocks That Should See a Surge in Interest Next Week

4 Pharma Stocks That Should See a Surge in Interest Next Week Seeking Alpha

View Article

The FDA's Drug Approval Agenda for Next Week

The FDA's Drug Approval Agenda for Next Week Seeking Alpha

View Article


Pain Therapeutics, Durect Shares Plunge on Pain Drug Rejection

Pain Therapeutics, Durect Shares Plunge on Pain Drug Rejection Minyanville,

View Article

Pleasure And Pain For Pfizer

Pleasure And Pain For Pfizer Investopedia

View Article

Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks

Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks Seeking Alpha

View Article


Zogenix licenses once-a-month antipsychotic drug

Zogenix licenses once-a-month antipsychotic drug Yahoo/AP

View Article


Pain Management Stocks: Will This Painful Downturn End Soon?

Pain Management Stocks: Will This Painful Downturn End Soon? Seeking Alpha

View Article

Durect plunges 33% on failed drug study

Durect plunges 33% on failed drug study Marketwatch

View Article

Durect's partner Pfizer to end pain drug deal

Durect's partner Pfizer to end pain drug deal Reuters

View Article

Durect reports Hospira returns rights to Posidur in U.S. and Canada

Durect reports Hospira returns rights to Posidur in U.S. and Canada Yahoo/Fly on the Wall

View Article


3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days

3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days Seeking Alpha

View Article

Durect Corporation: A Biopharma With No Debt

Durect Corporation: A Biopharma With No Debt Seeking Alpha

View Article


Pfizer Spooks Durect Investors, Creates Opportunity

Pfizer Spooks Durect Investors, Creates Opportunity Yahoo/Reuters

View Article

Where Is Pfizer Heading With The Patent Cliff?

Where Is Pfizer Heading With The Patent Cliff? Seeking Alpha

View Article


FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation

FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation Seeking Alpha

View Article

Pfizer: What Will Drive The Behemoth Forward?

Pfizer: What Will Drive The Behemoth Forward? Seeking Alpha

View Article

2014 Biotechnology Catalysts

2014 Biotechnology Catalysts Seeking Alpha

View Article
Browsing all 20 articles
Browse latest View live




Latest Images